Viewing Study NCT06738303

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:18 PM
Ignite Modification Date: 2026-01-29 @ 10:15 AM
Study NCT ID: NCT06738303
Status: RECRUITING
Last Update Posted: 2025-08-27
First Post: 2024-12-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer
Sponsor: Case Comprehensive Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Prostate Cancer View
None Metastatic Castration-resistant Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cabazitaxel View
None Lu-PSMA-617 View
None Carboplatin View